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Abstract
New triorganotin(IV) complexes of the type PhSnL3, BuSnL3 and MeSnL3 were constructed with the ligand benzamidoala-
nine, which was formed by reaction of benzoyl chloride with alanine in the presence of sodium hydroxide. The complexes were
characterized by elemental analysis, conductance measurements and infrared, ultraviolet visible and 1H, 13C and 119Sn nuclear
magnetic resonance spectroscopy. Monomer structures were proposed from the spectral measurements, with a bidentate form. All
compounds were screened for antibacterial (Staphylococcus  aureus  ATCC-9144, S.  epidermidis  ATCC-155, Micrococcus  luteus
ATCC-4698, Bacillus  cereus  ATCC-11778, Escherichia  coli  ATCC-25922 and Pseudomonas  aeruginosa  ATCC-2853) and anti-
fungal (Aspergillus  niger  ATCC-9029 and A.  fumigatus  ATCC-46645) activity by paper disc diffusion. The minimum inhibitory
concentrations of the compounds were determined by agar streak dilution. MeSnL3 was the most potent antimicrobial agent when
compared with ciprofloxin and ketoconazole.
We describe here a simple, convenient route for synthesizing new organotin derivatives for antimicrobial evaluation.
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Organotin carboxylates have attracted considerable
attention because of their wide application in many fields
[1–3]. The coordination number and environment of the
tin atom in organotin carboxylates can be controlled by
adjusting the steric and electronic factors of the car-
boxylic acid ligands and substituents linked to the tin
atom [3,4]. Many investigations have been conducted on
organotin carboxylates with functionalized carboxylic
acids and additional O, S or N donor groups [5].The structural diversity of organotin carboxylates is
well recognized. In the presence of additional coordinat-
ing atoms, some organotin carboxylates have fascinating
structures, such as hexameric cyclic forms [6,7], with a
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ide variety of coordination geometries [8]. It is consid-
red that a combination of steric and electronic factors
etermine the specific structure adapted by a particular
rganotin carboxylate [9], as supported by observation
f monomeric, dimeric, tetrameric, oligomeric ladder,
yclic and drum structures. Furthermore, it has been
eported that the size of the carboxylic acid used and
he stoichiometry of the reactants play important roles
n the formation of solid state frameworks.
Organotin compounds have a wide range of appli-
ations [10], including biological activity as potential
ntineoplastic and anti-tuberculosis agents [11,12], plas-
ic stabilizers [13,14] and polymer catalysts [15]. Recent
tudies on organotin carboxylates have involved either
ingle crystal structure determination or spectroscopy
16]. We undertook the preparation and characterization
f three organotin complexes with benzamidoalanine:
riphenyltin(IV)bis(benzamidoalanine) (Ph3SnL),
ributyltin(IV)bis(benzamidoalanine) (Bu3SnL) and
rimethyltin(IV) bis(benzamidoalanine) (Me3SnL) and
etermined their antimicrobial activity.
.  Materials  and  methods
.1.  Synthesis  of  benzamidoalanine
One gram (5 mmol) of alanine was dissolved in 25 ml
f 5% NaOH solution in a conical flask. Benzoyl chloride
2.25 ml, 20 mmol) was added in five 0.5-ml increments,
nd the flask was shaken vigorously until all the chloride
ad reacted. After acidification with diluted hydrochlo-
ic acid (1 ml), the crude product was washed with
old ether. The desired product was recrystallized from
thanol.
.2.  Preparation  of  complexes
Triorganotin salts (0.199 g, 1 mmol) were added drop
ise with constant stirring to a hot toluene solution of the
igand (0.193 g, 1 mmol). Then, the solution was refluxed
or 6 h with a magnetic stirrer, cooled and filtered.
fter drying at 60 ◦C, the solid obtained was recrystal-
ized in a mixture of ethanol and petroleum ether. The
urity of the ligand and its complexes were checked
y thin-layer chromatography with silica gel-G as the
dsorbent.
.3.  SpectroscopyElemental C, H, N and S analysis was carried
ut on a Fison EA 1108 analyser, and Fourier trans-
orm infrared spectra in the range 4000–370 cm−1 weresity for Science 8 (2014) 276–281 277
recorded as potassium bromide discs on a Perkin-Elmer
spectrophotometer GX. Molar conductance measure-
ments were made in anhydrous dimethylformamide at
25 ◦C on an Inolop-Cond Level 1 WTW. The atomic
absorption spectra of the complexes were measured on a
Shimadzu 680-cc spectrometer. The 1H, 13C and 119Sn
nuclear magnetic resonance spectra were recorded on
a Jeol 400 MHz spectrometer, relative to the internal
standard tetramethylsilane. Melting-points were deter-
mined in open capillary tubes with an Electrothermal
9300 digital apparatus.
2.4.  Biological  investigations
The antibacterial activity of the synthesized com-
pounds was tested in four Gram-positive bacteria
(Staphylococcus  aureus  ATCC-9144, S.  epidermidis
ATCC-155, Micrococcus  luteus  ATCC-4698 and Bacil-
lus cereus  ATCC-11778) and three Gram-negative
bacteria (Escherichia  coli  ATCC-25922 and Pseu-
domonas aeruginosa  ATCC-2853) in nutrient agar
medium. The antifungal activity of the compounds was
tested in Aspergillus  niger  ATCC-9029 and A.  fumiga-
tus ATCC-46645 in Sabouraud dextrose agar. All the
fungal and mould strains were clinical isolates, charac-
terized by conventional morphological and biochemical
methods.
The medium was sterilized by autoclaving at 120 ◦C
for 30 min, inoculated at a temperature of 40–50 ◦C
with 1 mL/100 mL of suspensions (105 cfu mL−1) of
the microorganisms (matched to McFarland barium
sulfate standard) and poured onto a petri dish to
a depth of 3–4 mm. Filter paper impregnated with
the test compounds (g/mL in dimethylformamide)
was placed on the solidified medium. The plates
were pre-incubated for 1 h at room temperature and
incubated at 37 ◦C for 24 and 48 h for antibacterial
and antifungal activities, respectively. Ciprofloxacin
(100 g/disc) and ketoconazole (100 g/disc) were used
as standards for antibacterial and antifungal activity,
respectively.
The minimum inhibitory concentrations (MICs), the
lowest concentrations of the test substances exhibiting
no visible growth of bacteria or fungi on the plate, were
determined by the agar streak dilution method. Stock
solutions of the synthesized compounds (100 g/mL) in
dimethylformamide were prepared, and graded quanti-
ties were incorporated into specified quantities of molten
sterile nutrient agar for determination of antibacterial
activity and in Sabouraud dextrose agar medium for
antifungal activity.
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Table 1
Physical data for ligand and organotin complexes.
Compound Colour Yield (%) Melting-point (◦C) Found (calculated) (%)
C H N Sn
Ligand White 75 165–166 62.32 5.81 7.17 –
(62.17) (5.74) (7.25)
Ph3SnL White 83 149–151 57.65 4.99 4.12 17.71
(62.02) (4.65) (2.58) (21.89)
Bu3SnL White 78 161–162 53.79 6.44 3.82 19.93
(54.79) (7.73) (2.90) (24.62)Me3SnL White 75 177–179 
3.  Results  and  discussion
3.1.  Synthesis  and  characterization  of  organotin
complexes
Table 1 shows the physical characteristics of the
ligand and the complexes. The conductance of the
complexes at room temperature was in the range
8–18 −1 cm2 mol−1, suggesting a non-electrolytic
nature. The calculated values for elemental C, H, N and S
and tin were in a good agreement with the experimental
values.
The Fourier transform infrared spectrum of the lig-
and showed characteristic stretching absorption bands
at 3371 cm−1, 3328 cm−1, 1611 cm−1 and 1332 cm−1,
which were assigned to υ(OH), υ(N H), υ(COO) asym
and υ(COO) sym, respectively. The COO stretching
vibrations are important for predicting the bonding mode
of the ligand. The values of υ  [υ  = υ asym (COO) −  υ
sym (COO)] can be divided into three groups [17]. (i)
In compounds in which υ(COO) > 350 cm−1, the car-
boxylate group binds in a monodentate fashion, although
other, very weak intra- and intermolecular interactions
cannot be excluded. (ii) When υ  (COO) < 200 cm−1,
the carboxylate groups of these compounds can be con-
sidered to be bidentate. (iii) In compounds in which υ
(COO) > 200 cm−1 and <350 cm−1, an anisobidentate
state, intermediate between monodentate and bidentate,
occurs. It has been suggested that the υ  (COO) value
Table 2
Characteristic absorption bands of ligand and complexes.
Compound υ(O H) υ(COO) asym. 
Ligand 3771 1613 
Ph3SnL – 1539 
Bu3SnL – 1541 
Me3SnL – 1546 50.06 4.06 5.53 22.41
(43.86) (4.92) (3.93) (33.35)
in the chelating mode is less than that in the bridging
mode. On this basis, we propose that the investigated
compounds are chelating-type carboxylates. The dis-
appearance of the hydrogen from the hydroxyl group
on complexation indicates that complexation occurs at
the oxygen atom. The bands for υ(Sn C) and υ(Sn O)
were assigned at 531–556 and 443–447 cm−1, respec-
tively. The infrared data for the complexes are shown
in Table 2, which lists the stretching frequencies (υ)
of some of the characteristic groups in the ligand and
complexes.
The 1H NMR spectra of the compounds are shown in
Table 3. The spectra support the formation of a benzami-
doalanine chelate, which gives a single resonance near
δ 8.71 ppm attributable to the N H proton. The spec-
tra also show singlet OH peaks at δ  9.24 ppm due to a
hydroxyl group. The hydroxyl resonance is absent from
the spectra of the complexes, indicting deprotonation and
coordination of tin to the oxygen. A small increase in
the shift of the aromatic proton resonances of the lig-
and is seen on chelation with the triorganotin(IV) moiety
[18]. The complexes Ph2SnL2, Bu2SnL2 and Me2SnL2
showed additional signals. Methyltin (Sn CH3) was
seen at δ  1.35, 1.33 and 1.31 ppm as a sharp singlet at inte-
grates for the protons, accompanied by satellites due to
the 1H–119Sn coupling, which corresponds to the hydro-
gen atom of the methyl protons of Me–Sn for Me2SnL2.
In the dibutyltin(IV) complex, the butyl protons appear
as a multiple and a triplet in the range δ  1.55–0.72 ppm
υ(COO) sym. υ(Sn C) υ(Sn O)
1329 – –
1325 535 446
1321 537 445
1322 558 445
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Table 3
1H NMR spectral data (δ, ppm) of ligand and complexes.
Compound O H N H C H aromatic C (2)H aliphatic
Ligand 9.24 8.73 7.55–7.78 3.89
Ph2SnL2 – 8.71 7.49–7.81 3.85
Bu2SnL2 – 8.67 7.49–7.82 3.82
Me2SnL2 – 8.69 7.36–7.75 3.87
Table 4
13C NMR spectral data (δ, ppm) of ligand and complexes.
Compound C O amide C O acid C H aromatic C H2 aliphatic 119Sn
Ligand 165.32 170.43 127.74–131.55 42.65 –
PhSnL3 160.22 165.26 126.86–133.76 41.64 −120.31
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competitive challenges. The disease-causing microor-
ganisms are particularly vulnerable to man’s selfishness
for survival, who has sought to deprive them of their habi-
tat by using antimicrobial agents. These microorganisms
OuSnL3 160.24 166.14 
eSnL3 160.31 164.19 
ue to a CH2CH2CH2CH3 group. The aromatic protons
n Ph–Sn appear at 7.06–7.17 ppm [19].
Table 4 shows the most relevant 13C and 119Sn NMR
ata. Because of the poor solubility of the ligand and
ts complexes in CDCl3, their spectra were recorded in
2H6] DMSO. The C O resonance group of the com-
lexes at δ 160.22–160.31 ppm were shifted down from
he position in the free ligand, which appeared at δ
65.32 ppm. The shift was probably due to a decrease
n electron density at the carbon atoms when oxygen is
onded to metal ion [18]. This observation lends further
redibility to the conclusion that complexation occurs
hrough the oxygen atoms of the carboxylate group.
h2SnL2, Bu2SnL2 and Me2SnL2 showed resonance at
 −442.86, −436.83 and −431.49 ppm, respectively,
hich is well within the range for six-coordinated
omplexes. In Ph2SnL2, 119Sn resonance appeared, as
xpected, at a lower field region than in Bu2SnL2
nd Me2SnL2, despite the greater electron withdraw-
ng capability of the phenyl group. The resonance at δ
−442.86 ppm) probably reflects the greater shielding
bility of the phenyl group.The ultraviolet visible electronic spectrum of the lig-
nd benzamidoalanine in DMSO solvent is shown in
able 5. As expected, the complexes showed different
able 5
lectronic spectra for ligand and its complexes.
ompound Absorption bands (nm)
igand 282 301 328
hSnL3 328 328 340
uSnL3 296 287 334
eSnL3 280 290 3006.25–131.94 42.13 −122.25
27.4–131.44 41.38 −125.52
absorptions from that of the free ligand, with bands
shifted to different wavelengths. On the basis of these
findings, the suggested structure of the complexes is that
shown in Fig. 1.
3.2.  Antimicrobial  activity
Microorganisms have existed on the earth for more
than 3.8 billion years and exhibit the greatest genetic and
metabolic diversity. They are an essential component of
the biosphere and serve an important role in the main-
tenance and sustainability of ecosystems, comprising
about 50% of the living biomass. In order to survive, they
have evolved mechanisms that enable them to respond to
selective pressure exerted by various environments andNH
O
O Sn
R
R
R = -CH3 ,  -CH2CH2CH2CH3 and
H3C
R
Fig. 1. Deduced structure of organotin complexes with benzamidoala-
nine.
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have responded by developing resistance to this offen-
sive. Currently, antimicrobial resistance among bacteria,
viruses, parasites and other disease-causing organisms is
a serious threat to infectious disease management glob-
ally [20–23].
Antimicrobial agents act selectively on vital micro-
bial functions, with minimal or no effect on host function.
Different agents act differently; their mechanisms of
action can be categorized on the basis of their structure or
on the function that they affect, i.e. inhibition of cell wall
synthesis, of ribosome function, of nucleic acid synthe-
sis, of folate metabolism or of cell membrane function.
The resistance mechanisms therefore depend on which
pathways are inhibited by the drugs and whether the
organisms can modify those pathways [24–26]. Resis-
tance is either intrinsic or acquired. Microorganisms with
intrinsic or natural resistance either do not have target
sites for drugs or have low permeability to drugs because
of the chemical nature of the drug or the microbial mem-
brane structure. Acquired resistance, in which a naturally
susceptible microorganism acquires ways of not being
affected, can occur in various ways.
The synthesized compounds were moderately active
against the tested microorganisms, with ranges of MIC
values of 3.4–29.4 g/mL for S. aureus, 2.1–28.2 g/mL
for S.  epidermidis, 1.2–28.7 g/mL for M.  luteus,
2.0–27.7 g/mL for B.  cereus, 3.1–32.8 g/mL
for E.  coli, 2.4–36.2 g/mL for P.  aeruginosa,
1.1–34.2 g/mL for A.  niger  and 1.7–31.8 g/mL for A.
fumigatus. MeSnL3 was the most potent antimicrobial
agent, with MICs of 3.4, 2.1, 1.2, 2.0, 3.1, 2.4, 1.1
and 1.7 g/mL against S.  aureus, S.  epidermidis, M.
luteus, B.  cereus, E.  coli, P.  aeruginosa, A.  niger  and
A. fumigatus, respectively. MeSnL3 had significantly
greater antimicrobial activity than the standard drugs
ciprofloxin and ketoconazole. The potent antibacterial
and antifungal activity of MeSnL3 might be due to the
presence of a strong electron-withdrawing substituent,
with two nitro groups on the benzylideneamino moiety
of the 1,3,4-thiadiazole. Compounds containing weak
electron-withdrawing groups, like bromo and chloro,
and electron-donating groups like methoxy, methyl
and hydroxy groups, had weak antimicrobial activity
(Table 6).
4.  Conclusion
The antimicrobial activity of the synthesized com-
pounds may be due the presence of a versatile
pharmacophore, which might increase the lipophilic
character of the molecules and facilitate passage across
the membrane of the microorganism. MeSnL3 was the
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